» Articles » PMID: 31308668

Restless Arms Syndrome: Prevalence, Impact, and Management Strategies

Overview
Publisher Dove Medical Press
Specialty Psychiatry
Date 2019 Jul 17
PMID 31308668
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

This literature review focuses on restless arms syndrome (RAS), an upper limb variant of restless legs syndrome (RLS). RLS, also known as Willis-Ekbom disease, is a frequently occurring neurological disorder characterized by an irresistible urge to move the lower limbs often accompanied by unpleasant sensations in the legs, worsened at rest and in the evening, improved by movement. Extension of leg restlessness to the upper limbs is frequently reported in typical patients who had RLS only in the legs and usually occurs later in the course of RLS, restlessness remaining most invalidating in the lower limbs. In RAS, the arms are predominantly affected with little or no involvement of the legs. Cases of restless shoulders syndrome or periodic arm movements without arm restlessness were not considered. A total of 9 articles with 10 cases were included and analyzed for the adherence to the five essential diagnostic criteria of the International RLS Study Group (IRLSSG) classification, as well as for the additional supportive features. All of the reported cases were classified as having definite RAS. The clinical history and disease evolution of two previously reported patients were completed and updated. Overall, the clinical picture of RAS does not differ from that of RLS, except for the symptoms localization on the upper limbs. Underlying mechanisms of the spread of RLS to upper limb restlessness and of RAS remain unknown. Whether RAS is a phenotypic variant of RLS or a separate entity needs further investigations. RAS likely remains underdiagnosed and according to IRLSSG diagnostic criteria RAS should be considered when RLS-like symptoms are present in one or both arms, especially when they have a circadian pattern and are improved by movement and dopaminergic therapy. Clinicians should be aware of this rare condition, especially as treatment using dopaminergic agonists proves to be very efficient.

Citing Articles

Restless Back Syndrome: A Case Report and Literature Review.

Sun F, Tao H, Jin W Psychiatry Clin Psychopharmacol. 2024; 32(4):351-354.

PMID: 38764880 PMC: 11082566. DOI: 10.5152/pcp.2022.22441.


Restless arms syndrome with oral olanzapine: case based review.

Kuang Q, Zhou S, Huang R, Zheng Y, She S Heliyon. 2023; 8(12):e12258.

PMID: 36619467 PMC: 9816658. DOI: 10.1016/j.heliyon.2022.e12258.


Restless arm syndrome: a rare disease?.

Moser U, Schwab J BMJ Case Rep. 2021; 14(9).

PMID: 34544716 PMC: 8454428. DOI: 10.1136/bcr-2021-244890.


Transitory restless arms syndrome in a patient with antipsychotics and antidepressants: a case report.

Chen J, Meng N, Cao B, Ye Y, Ou Y, Li Z BMC Psychiatry. 2021; 21(1):453.

PMID: 34530775 PMC: 8447733. DOI: 10.1186/s12888-021-03433-6.


Restless Legs Syndrome: Contemporary Diagnosis and Treatment.

Gossard T, Trotti L, Videnovic A, St Louis E Neurotherapeutics. 2021; 18(1):140-155.

PMID: 33880737 PMC: 8116476. DOI: 10.1007/s13311-021-01019-4.


References
1.
Chabli A, Michaud M, Montplaisir J . Periodic arm movements in patients with the restless legs syndrome. Eur Neurol. 2000; 44(3):133-8. DOI: 10.1159/000008221. View

2.
Freedom T, Merchut M . Arm restlessness as the initial symptom in restless legs syndrome. Arch Neurol. 2003; 60(7):1013-5. DOI: 10.1001/archneur.60.7.1013. View

3.
EKBOM K . Restless legs syndrome. Neurology. 1960; 10:868-73. DOI: 10.1212/wnl.10.9.868. View

4.
Allen R, Picchietti D, Hening W, Trenkwalder C, Walters A, Montplaisi J . Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003; 4(2):101-19. DOI: 10.1016/s1389-9457(03)00010-8. View

5.
Gigli G, Adorati M, Dolso P, Piani A, Valente M, Brotini S . Restless legs syndrome in end-stage renal disease. Sleep Med. 2004; 5(3):309-15. DOI: 10.1016/j.sleep.2004.01.014. View